110 related articles for article (PubMed ID: 25331239)
1. HER 2 expression status in gastric carcinomas in Ibadan, Nigeria: a preliminary study using immunohistochemistry.
Ogun GO; Afuwape OO; Ayandipo OO; Oluwasola OA
Niger Postgrad Med J; 2014 Sep; 21(3):231-4. PubMed ID: 25331239
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract][Full Text] [Related]
3. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
[TBL] [Abstract][Full Text] [Related]
4. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.
Simpong DL; Asmah RH; Krampah C; Akakpo PK; Adu P; Asante DB; Naporo S; Adjei AA; Gyasi RK
ScientificWorldJournal; 2018; 2018():1564150. PubMed ID: 29725274
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C
J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747
[TBL] [Abstract][Full Text] [Related]
6. Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma.
Almhanna K; Rosa M; Henderson-Jackson E; Jiang K; Shamekh R; Sayegh Z; Malafa MP; Coppola D
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):633-638. PubMed ID: 26186253
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
Gupta P; Rao S; Bhalla S
Indian J Cancer; 2016; 53(4):505-511. PubMed ID: 28485339
[TBL] [Abstract][Full Text] [Related]
10. HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
Kunz PL; Mojtahed A; Fisher GA; Ford JM; Chang DT; Balise RR; Bangs CD; Cherry AM; Pai RK
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):13-24. PubMed ID: 21617522
[TBL] [Abstract][Full Text] [Related]
11. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
Shan L; Ying J; Lu N
Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer.
Zhang H; Wang Y; Wang Y; Wu D; Lin E; Xia Q
Pathol Res Pract; 2020 Nov; 216(11):153229. PubMed ID: 33010699
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of Her-2/neu overexpression in breast carcinoma in Nigerians: a 5-year retrospective study.
Ugiagbe EE; Olu-Eddo AN; Obaseki DE
Niger J Clin Pract; 2011; 14(3):332-7. PubMed ID: 22037080
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
15. [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].
Lee SW; Kang SB; Kim YS; Nam SW; Lee DS; Lee HK; Han SW
Korean J Gastroenterol; 2007 Mar; 49(3):152-7. PubMed ID: 18172343
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach.
Honda T; Tamura G; Endoh Y; Nishizuka S; Kawata S; Motoyama T
Jpn J Clin Oncol; 2005 Oct; 35(10):580-6. PubMed ID: 16254038
[TBL] [Abstract][Full Text] [Related]
17. HER2 testing in gastric cancer: molecular morphology and storage time-related changes in archival samples.
Risio M; De Rosa G; Sarotto I; Casorzo L; Capussotti L; Torchio B; Aglietta M; Chiecchio L
Int J Oncol; 2003 Nov; 23(5):1381-7. PubMed ID: 14532980
[TBL] [Abstract][Full Text] [Related]
18. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.
Farzand S; Siddique T; Saba K; Bukhari MH
World J Gastroenterol; 2014 May; 20(19):5889-96. PubMed ID: 24914350
[TBL] [Abstract][Full Text] [Related]
19. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
Nadaf AS; Rani H; Dinesh US
Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
[TBL] [Abstract][Full Text] [Related]
20. Is Helicobacter pylori a poor prognostic factor for HER-2 SISH positive gastric cancer?
Selcukbiricik F; Tural D; Erdamar S; Buyukunal E; Demirelli F; Serdengecti S
Asian Pac J Cancer Prev; 2013; 14(5):3319-22. PubMed ID: 23803123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
